TODD MALVEY: Open Payments
NPI 1811093198 · NORTHBOROUGH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,154 in 138 payments from 37 companies in 2025. Trend: 2023 $2,774 · 2024 $3,953 · 2025 $3,154
Food & beverage: $3,154
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 12 | $317 |
| Lilly USA, LLC | 11 | $298 |
| ABBVIE INC. | 12 | $266 |
| PFIZER INC. | 10 | $205 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $176 |
| Inspire Medical Systems, Inc. | 12 | $158 |
| AstraZeneca Pharmaceuticals LP | 7 | $158 |
| Exact Sciences Corporation | 6 | $136 |
| Alnylam Pharmaceuticals Inc. | 5 | $135 |
| SCPHARMACEUTICALS INC. | 5 | $107 |
Products named: MOUNJARO, JARDIANCE, INSPIRE, Cologuard Collection Kit, ONPATTRO, FUROSCIX, VYNDAQEL, VOQUEZNA.
Industry payments across MA — which companies pay providers there.
